Tokyo, March 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061092) titled 'Impact of Heparin Calcium Supply Discontinuation on Deep Vein Thrombosis Incidence: an observational study' on March 28.
Study Type:
Observational
Primary Sponsor:
Institute - Akashi Medical Center
Condition:
Condition - Deep Vein Thrombosis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - We aimed to verify whether the discontinuation of heparin Ca supply led to an increase in deep vein thrombosis.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients of medical institutions belonging to the Japan Collaborative Network
Key exclusion criteria - Patients without an ICD-10-CM code
Target Size - 4338625
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2026 Year 03 Month 09 Day
Date of IRB - 2026 Year 03 Month 17 Day
Anticipated trial start date - 2026 Year 03 Month 28 Day
Last follow-up date - 2026 Year 03 Month 28 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069906
Disclaimer: Curated by HT Syndication.
